Keyword : EGFR mutations
Systemic treatment of locally advanced and metastatic EGFR-mutated NSCLC. What’s new?Т. 16, №2 (62)
Erlotinib efficacy as first-line treatment for patients with advanced EGFR
mutation-positive non-small-cell lung cancerAuthor:Toracica Oncologia Italiana Associazione and Pneumo-Cancerologie de Francais Groupe with collaboration in Group Cancer Lung Spanish №7 (3) 2012
